NIH Launches Trial for Potential Enterovirus D68 Treatment
The NIH is conducting a clinical trial to assess the safety and optimal dosage of an investigational monoclonal antibody developed from blood of recovering patients.
The NIH is conducting a clinical trial to assess the safety and optimal dosage of an investigational monoclonal antibody developed from blood of recovering patients.
The NIH is conducting a clinical trial to assess the safety and optimal dosage of an investigational monoclonal antibody developed from blood of recovering patients.
Read MoreEpidemiological researchers have found more evidence of links between the respiratory virus enterovirus D68 and acute flaccid myelitis, a rare, paralyzing neurologic disease.
Read MoreA CDC report reveals the timeline of enterovirus D68 closely resembles that of acute flaccid myelitis (AFM), a mysterious polio-like illness that has caused paralysis in children.
Read MoreSix New Yorkers have been diagnosed with Acute Flaccid Myelitis, a rare and mysterious illness...
Read MoreState and federal health officials confirmed Florida’s first case of Acute Flaccid Myelitis in...
Read More